Inflammatory bowel disease: short- and long-term treatments.
Bickston
S J
SJ
Division of Gastroenterology and Hepatology, University of Virginia Health Sciences Center, USA.
Cominelli
F
F
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D003424:Crohn Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D016207:Cytokines / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D016023:Integrins / Q000037:antagonists & inhibitors; D007937:Leukapheresis; D010288:Parenteral Nutrition; D016737:Proctocolectomy, Restorative; D012460:Sulfasalazine / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D016207:Cytokines; D005765:Gastrointestinal Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016023:Integrins; D012460:Sulfasalazine; D001241:Aspirin